Clinical Trial Update: Gemcitabine and Cisplatin With Ivosidenib or Pemigatinib for the Treatment of Unresectable or Metastatic Cholangiocarcinoma [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating gemcitabine and cisplatin with either ivosidenib or pemigatinib for unresectable or metastatic cholangiocarcinoma; the study is termina…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma

Drugs mentioned

• Gemzar (gemcitabine)
• Pemazyre (pemigatinib)
• Platinol (cisplatin)
• Tibsovo (ivosidenib)

Snippet

Sponsor: Academic and Community Cancer Research United | Conditions: Advanced Cholangiocarcinoma, Metastatic Cholangiocarcinoma | Phase 1 | Status: TERMINATED | Results posted: 2024-05-02